Clinical trial
Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients…
NCT00002664 · James Ahlgren, Other · Withdrawn
Key facts
| NCT number | NCT00002664 |
|---|---|
| Title | Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer |
| Official title | PHASE II STUDY OF MONOCLONAL ANTIBODY 17-1A WITH GM-CSF IN TREATMENT OF 5-FU RESISTANT COLORECTAL CANCER |
| Lead sponsor | James Ahlgren, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological |
| Interventions | edrecolomab, sargramostim |
| Enrollment | 0 |
| Start date | Jul 1, 1995 |
| Primary completion | Feb 22, 2017 |
| Completion | Feb 22, 2017 |
| First posted | May 24, 2004 |
| Last update posted | Jul 13, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: